Get started

PHARMA

Amarin Corporation: A Hidden GemGood afternoon. I would be glad if you subscribe to me in TradingView so you can be the first to read my new ideas. Overly grateful for your likes. In the comments, you can ask questions about the company. Summary Technical analysis On the chart, we can see the imminent completion of corrective wave 2 and the appearance of impulse wave 3. Several indicators support the uptrend, including the RSI indicator. In addition, this indicator confirms the Elliott Wave labeling. On the 1D chart, we can see an open gap in the area of $8.4-12.8 per share. The company's shares are currently in an uptrend. In addition, Amarin shares are just above the EMA 55 and EMA 89, which also confirms the uptrend. Fundamental Analysis You can read a complete fundamental analysis of the company in my analytical article in SA. Conclusion Considering the above factors, I believe that the growth of Amarin shares will continue. Disclosure: This article may not take into account all the risks and catalysts for the stocks described in it. Any part of this analytical article is provided for informational purposes only, does not constitute an individual investment recommendation, investment idea, advice, offer to buy or sold securities, or other financial instruments. The completeness and accuracy of the information in the analytical article are not guaranteed. If any fundamental criteria or events change in the future, I do not assume any obligation to update this article.
NASDAQ:AMRNLong
by UnknownUnicorn28205834
1
OptiNose: Maximum OptimismGood afternoon. I would be glad if you subscribe to me in TradingView so you can be the first to read my new ideas. Overly grateful for your likes. In the comments, you can ask questions about the company. Summary: Technical analysis: On the chart, we can see the completion of corrective wave 2 and the emergence of impulse wave 3. According to the RSI indicator, we can see an uptrend, which confirms the labeling of the Elliott waves. On the 1D chart, we can see an open gap in the area of $6-7 per share. Currently, the company's shares are in the area of the downtrend breakout. In addition, Optinose shares have broken through EMA 55 and are just below EMA 89. Fundamental Analysis: You can read a complete fundamental analysis of the company in my analytical article in SA. Conclusion Considering the above factors, I believe that the growth of Optinose shares will continue. Disclosure: This article may not take into account all the risks and catalysts for the stocks described in it. Any part of this analytical article is provided for informational purposes only, does not constitute an individual investment recommendation, investment idea, advice, offer to buy or sold securities, or other financial instruments. The completeness and accuracy of the information in the analytical article are not guaranteed. If any fundamental criteria or events change in the future, I do not assume any obligation to update this article.
NASDAQ:OPTNLong
by UnknownUnicorn28205834
1
EDIT Editas medicine ready to break outBeen in this for a little while now since the change in market structure and added a few times to this position so not the best avg weighted entry but still well in profit. Classic sweep of lows and change in market structure has me excited on this position and more recently over the last month with the gap up above the previous short term high and now the ascending triangle forming showing the bulls still buying up and testing that resistance. The resistance may be strong but we have had a few cracks at it already and eventually I expect this level to break and to see another descent impulse move. Bullish on EDIT for now, momentum still on our side.
NASDAQ:EDITLong
by DeNomics
1
Do you have Diamond Hands? Check out NXRP's Volatile Reversal...NRXP is in for a wild & volatile ride where it may reverse & double in value or even more. Technicals support a reversal over weeks with a current strong trend on the daily. Fundamentals are strong; F-Score is 9 & they just had some major news catalysts including a COVID-19 Treatment drug. High risk with potentially high reward: up to a 25% drawdown and a potential 100+% gain leading to a 4:1 risk to reward ratio. With a ~30% short interest this could be a wild ride like GME or AMC. Risk management by day trading may be possible.
NASDAQ:NRXPLong
by jsgiardino
Vaccine Counter PHARMA Downtrend SignsSupposedly the beneficiary of the vaccine story as one of the appointees approved by the government. A duopoly with DPHARMA. However... their price & volume action is dimming fast.. The cup and handle pattern is invalidated. The recent decision to prioritize Pfizer vaccine over Sinovac really trigger a sell-down on PHARMA stock price with high volume. Expect continued selling in the coming days. www.straitstimes.com The rest of the vaccine related stock hype: Kanger, Solution, HWGB, Yongtai, Bintai , yet to see any new development as the government controlled tightly the distribution and sale of vaccine to the public from third parties. Disclaimer This information only serves as reference information and does not constitute a buy or sell call. Conduct your own research and assessment before deciding to buy or sell any stock
MYX:PHARMAShort
by Gilazilla
Long IVERIC ($ISEE) this stock is about to breakout. I am long ISEE. I see this stock is about to POP (but watching closely in case it is a bust). I am long ISEE because We broke $9, previous resistance There are no other resistance areas until last sell off in 2017 MACD cross over bullish RSI bullish with HH Break out of BBand after narrow band Pharma is all the rage :D Our target prices are 22.8 then 30.21 at previous resistance. However, if this pops I can imagine it reaching a new ATH, or getting close to what it managed a couple years ago. But I will not be greedy ;-) Closing if we break support at 5.77 Cheers x
ILong
by UnknownUnicorn11444931
1